Acetyl Hexapeptide-8 vs Matrixyl
A side-by-side research comparison of Acetyl Hexapeptide-8 and Matrixyl across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Acetyl Hexapeptide-8 | Matrixyl |
|---|---|---|
| Full name | Acetyl Hexapeptide-8 (Argireline Advanced) | Matrixyl (Palmitoyl Pentapeptide-4 / Pal-KTTKS) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Same SNARE complex competition as argireline with acetyl modification for improved stability and cellular uptake. | Signals through TGF-B pathway to stimulate fibroblast production of collagen I, III, IV, fibronectin, and hyaluronic acid. Palmitoyl chain enhances penetration. |
| Molecular weight | 889 Da | 802.1 Da |
| Half-life | 10-14 hours | 6-12 hours (topical depot) |
| Bioavailability | Improved (topical, acetylated) | Moderate (topical) |
| Typical dose | 5-10% | 2-8% in serum/cream |
| Frequency | 2x daily | 1-2x daily |
| Route | Topical | Topical |
Acetyl Hexapeptide-8 reported benefits
- Improved stability
- Expression wrinkle reduction
- Preventative anti-aging
- Compatible with most formulations
Matrixyl reported benefits
- Stimulates collagen I, III, IV
- Reduces wrinkle depth up to 45%
- Increases skin thickness
- Improves firmness
- Enhances hydration
Related comparisons
Research and educational reference only. Not medical advice.